{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:52:14Z","timestamp":1784332334542,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London"},{"name":"Maudsley NHS Foundation Trust and King\u2019s College London"},{"DOI":"10.13039\/100011404","name":"Indivior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011404","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.drugalcdep.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T07:20:36Z","timestamp":1543216836000},"page":"438-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Change in alcohol and other drug use during five years of continuous opioid substitution treatment"],"prefix":"10.1016","volume":"194","author":[{"given":"Brian","family":"Eastwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-2725","authenticated-orcid":false,"given":"John","family":"Strang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-2498","authenticated-orcid":false,"given":"John","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugalcdep.2013.03.001","article-title":"Ultra-rapid screening for substance-use disorders: the alcohol, smoking and substance involvement screening test (ASSIST-Lite)","volume":"132","author":"Ali","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.addbeh.2011.11.003","article-title":"Stimulant use trajectories and the longitudinal risk of heavy drinking: findings from a rural population-based study","volume":"37","author":"Borders","year":"2012","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2008.01.021","article-title":"Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users","volume":"96","author":"Brecht","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1360-0443.1998.9344935.x","article-title":"Marijuana use and treatment outcome among opioid\u2010dependent patients","volume":"93","author":"Budney","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0030","series-title":"Drug Misuse and Dependence: UK Guidelines on Clinical Management","author":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0035","series-title":"The ROSIE Study: Drug Treatment Outcomes in Ireland","author":"Comiskey","year":"2009"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0040","doi-asserted-by":"crossref","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(95)01171-9","article-title":"Levels and correlates of polydrug use among heroin users and regular amphetamine users","volume":"39","author":"Darke","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addbeh.2015.06.030","article-title":"Patterns and correlates of alcohol use amongst heroin users: 11-year follow-up of the Australian Treatment Outcome Study cohort","volume":"50","author":"Darke","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2006.03.004","article-title":"Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study","volume":"84","author":"Darke","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0060","series-title":"Index of Multiple Deprivation (IMD)","author":"Department for Communities and Local Government","year":"2007"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2018.03.052","article-title":"Continuous opioid substitution treatment over five years: heroin use trajectories and outcomes","volume":"188","author":"Eastwood","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drugalcdep.2017.03.013","article-title":"Effectiveness of treatment for opioid use disorder: a national, five-year, prospective, observational study in England","volume":"176","author":"Eastwood","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","article-title":"Does Cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? A review of past findings, and more evidence against","volume":"98","author":"Epstein","year":"2003","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","article-title":"The national treatment outcome research study (NTORS): 4-5 year follow-up results","volume":"98","author":"Gossop","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0376-8716(01)00178-8","article-title":"Changes in use of crack cocaine after drug misuse treatment: 4\u20135 year follow-up results from the National Treatment Outcome Research Study (NTORS)","volume":"66","author":"Gossop","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0376-8716(01)00178-8","article-title":"Changes in use of crack cocaine after drug misuse treatment: 4-5 year follow-up results from the National Treatment Outcome Research Study (NTORS)","volume":"66","author":"Gossop","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0095","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1046\/j.1360-0443.2002.00227.x","article-title":"Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses","volume":"97","author":"Gossop","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2011.04.004","article-title":"30-Year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California","volume":"118","author":"Grella","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.addbeh.2017.10.013","article-title":"Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack","volume":"77","author":"Heidebrecht","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","article-title":"Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS)","volume":"25","author":"Hubbard","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2014.03.018","article-title":"Development of the addiction dimensions for assessment and personalised treatment (ADAPT)","volume":"139","author":"Marsden","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0120","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(09)61420-3","article-title":"Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study","volume":"374","author":"Marsden","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0125","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1111\/j.1360-0443.2012.03971.x","article-title":"Risk adjustment of heroin treatment outcomes for comparative performance assessment in England","volume":"107","author":"Marsden","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0130","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1360-0443.2008.02284.x","article-title":"Development of the treatment outcomes profile","volume":"103","author":"Marsden","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0135","article-title":"Memory-focused cognitive therapy for cocaine use disorder: theory, procedures and preliminary evidence from an external pilot randomised controlled trial","volume":"0","author":"Marsden","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cct.2016.12.003","article-title":"Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: study protocol for a pragmatic randomised controlled trial","volume":"53","author":"Marsden","year":"2017","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0155","series-title":"Finite Mixture Models","author":"McLachlan","year":"2000"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1360-0443.2005.01012.x","article-title":"Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring","volume":"100","author":"McLellan","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0165","first-page":"11","article-title":"Alcohol use in opioid agonist treatment","author":"Nolan","year":"2016","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0170","series-title":"Adult Substance Misuse Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2017 to 31 March 2018","author":"Public Health England","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0175","series-title":"Quality and Methodology Information","author":"Public Health England","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0180","series-title":"Adult Substance Misuse Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2016 to 31 March 2017","author":"Public Health England","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0185","series-title":"Adult Substance Misuse Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2015 to 31 March 2016","author":"Public Health England","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0190","series-title":"Adult Substance Misuse Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2014 to 31 March 2015","author":"Public Health England","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0195","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/add.14059","article-title":"Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders","volume":"113","author":"Russolillo","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addbeh.2015.04.006","article-title":"Evaluating racial disparity in referral source and successful completion of substance abuse treatment","volume":"48","author":"Sahker","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0205","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","article-title":"Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal","volume":"248","author":"Scavone","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0210","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/009145099502200306","article-title":"Keeping off, stepping on and stepping off: the steppingstone theory reevaluated in the context of the dutch Cannabis experience","volume":"22","author":"Sifaneck","year":"1995","journal-title":"Contemp. Drug Probl."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1037\/0033-3204.30.2.357","article-title":"Motivation as a predictor of early dropout from drug abuse treatment","volume":"30","author":"Simpson","year":"1993","journal-title":"Psychother. Theory Res. Pract. Train."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0220","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archpsyc.1982.04290110070012","article-title":"Six-year follow-up of opioid addicts after admission to treatment","volume":"39","author":"Simpson","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0899-3289(95)90309-7","article-title":"Client engagement and change during drug abuse treatment","volume":"7","author":"Simpson","year":"1995","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addbeh.2016.02.030","article-title":"Residential and outpatient treatment completion for substance use disorders in the U.S.: moderation analysis by demographics and drug of choice","volume":"58","author":"Stahler","year":"2016","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0235","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/add.13747","article-title":"Trajectories of heroin use: 10\u201311-year findings from the Australian Treatment Outcome Study","volume":"112","author":"Teesson","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2005.11.009","article-title":"One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)","volume":"83","author":"Teesson","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0245","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.drugpo.2007.06.004","article-title":"Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin","volume":"19","author":"Valdez","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.02.030","article-title":"Long-term outcomes from the national drug abuse treatment clinical trials network prescription opioid addiction treatment study","volume":"150","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0255","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/add.12971","article-title":"Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England","volume":"110","author":"White","year":"2015","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugalcdep.2016.01.020","article-title":"Is treatment for alcohol use disorder associated with reductions in criminal offending? A national data linkage cohort study in England","volume":"161","author":"Willey","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.008_bib0265","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/hec.999","article-title":"Benefits and costs of methadone treatment: results from a lifetime simulation model","volume":"14","author":"Zarkin","year":"2005","journal-title":"Health Econ."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618304897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618304897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T18:32:57Z","timestamp":1717266777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618304897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":53,"alternative-id":["S0376871618304897"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.11.008","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in alcohol and other drug use during five years of continuous opioid substitution treatment","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}